As expected, NAbs were significantly correlated with anti-S1 IgG and anti-RBD IgG, but not with anti-NP IgG (Fig. 1e), suggesting that anti-S1 IgG and anti-RBD IgG may be the predictors of serum neutralizing ability in COVID-19 patients. Here, PSMD1 is linked to COVID-19.